Christopher Peetz
President and CEO at Mirum Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Mirum Pharmaceuticals Inc., 3 years.
Mirum Pharmaceuticals Inc.
Director · CHIEF EXECUTIVE OFFICER
Chief executive roles
Mirum Pharmaceuticals Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 10, 2024 | Mirum Pharmaceuticals Inc. | Grant or award | +817 | $21.05 | $17,198 |
| Feb 2, 2024 | Mirum Pharmaceuticals Inc. | Open-market sale | −6,013 | $26.19 | $157,480 |
| Jan 8, 2024 | Mirum Pharmaceuticals Inc. | Open-market sale | −5,209 | $28.03 | $146,008 |
| Jul 3, 2023 | Mirum Pharmaceuticals Inc. | Open-market sale | −5,498 | $25.65 | $141,024 |
| May 10, 2023 | Mirum Pharmaceuticals Inc. | Grant or award | +1,256 | $16.92 | $21,252 |
| Jan 31, 2023 | Mirum Pharmaceuticals Inc. | Grant or award | +50,000 | — | — |
| Jan 9, 2023 | Mirum Pharmaceuticals Inc. | Open-market sale | −5,159 | $20.62 | $106,379 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.